Eli Lilly also received two additional warning letters for sponsored content presented as news about Mounjaro that contained false and misleading claims. This report is prepared using the most recent information posted in the FDAs Enforcement Reports Database (for recalls), Warning Letters Database (for warning letters), and Drug Imports Alerts Database (for drug importers subject to import bans)
& Mauvais-Jarvis, F
Last month, Eli Lilly, the maker of retatrutide, released top-line results from its late-stage (phase 3) clinical trial named TRIUMPH1
doi:10.1056/NEJMoa2028198 8
When used as part of a broader weight management strategy, including diet, exercise, and lifestyle adjustments, these medications have been shown to be safe and effective for extended periods, with mild side effects like nausea typically diminishing over time
But, you can track markers related to your metabolic health, such as HbA1c and cholesterol instead